TrianglePUBLICATIONS · 38867349
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer Discov
- Publication date
- 2024 Sep 4
- First author
- Stieglitz E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Stieglitz E
- type
- Author
- name
- Lee AG
- type
- Author
- name
- Angus SP
- type
- Author
- name
- Davis C
- type
- Author
- name
- Barkauskas DA
- type
- Author
- name
- Hall D
- type
- Author
- name
- Kogan SC
- type
- Author
- name
- Meyer J
- type
- Author
- name
- Rhodes SD
- type
- Author
- name
- Tasian SK
- type
- Author
- name
- Xuei X
- type
- Author
- name
- Shannon K
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Stieglitz E
- type
- Author
- name
- Lee AG
- type
- Author
- name
- Angus SP
- type
- Author
- name
- Davis C
- type
- Author
- name
- Barkauskas DA
- type
- Author
- name
- Hall D
- type
- Author
- name
- Kogan SC
- type
- Author
- name
- Meyer J
- type
- Author
- name
- Rhodes SD
- type
- Author
- name
- Tasian SK
- type
- Author
- name
- Xuei X
- type
- Author
- name
- Shannon K
- type
- Author
- bibliography ids
- nci-bib-5afed3f47cab564b1753018c
- book metadata
- content sha256
- 56db9e0f4b3310d30e7c99fba04ef97ca0c4446202d0938ecd4a3009a7a3e4bd
- document type
- citation
- dois
- 10.1158/2159-8290.CD-23-1376
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38867349
- immutable id
- pubmed:38867349@56db9e0f4b3310d30e7c99fba04ef97ca0c4446202d0938ecd4a3009a7a3e4bd
- journal
- abbreviation
- Cancer Discov
- issn electronic
- 2159-8290
- issn print
- 2159-8274
- issue
- 9
- name
- Cancer discovery
- nlm unique id
- 101561693
- pages
- 1590-1598
- volume
- 14
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38867349
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- 17862b183750ba761befe80aba07fc93f7d8a9c8ae40f15513d6a478a12b13ca
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2024 Sep 4
- precision
- day
- year
- 2024
- publication types
- Journal Article
- Clinical Trial, Phase II
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.
Preserved source evidence · Not medical advice